First Time Loading...

Mirati Therapeutics Inc
NASDAQ:MRTX

Watchlist Manager
Mirati Therapeutics Inc Logo
Mirati Therapeutics Inc
NASDAQ:MRTX
Watchlist
Price: 58.7 USD Market Closed
Updated: May 16, 2024

Mirati Therapeutics Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mirati Therapeutics Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Mirati Therapeutics Inc
NASDAQ:MRTX
Total Other Income
$37.2m
CAGR 3-Years
543%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Other Income
-$4.7B
CAGR 3-Years
6%
CAGR 5-Years
-204%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$252m
CAGR 3-Years
22%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$151m
CAGR 3-Years
126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$15.3m
CAGR 3-Years
N/A
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
-$31.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mirati Therapeutics Inc's Total Other Income?
Total Other Income
37.2m USD

Based on the financial report for Sep 30, 2023, Mirati Therapeutics Inc's Total Other Income amounts to 37.2m USD.

What is Mirati Therapeutics Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
64%

Over the last year, the Total Other Income growth was 417%. The average annual Total Other Income growth rates for Mirati Therapeutics Inc have been 543% over the past three years , 64% over the past five years .